Kymera Share Price

Kymera Share Price

NASDAQ: KYMR | Large Cap | Healthcare
$121.21
-$0.13 (-0.1%) Last updated on 19 Nov, 2026 | 02:29 IST
  • Performance
  • Chart
  • Fundamentals
  • Profit & Loss
  • Balance Sheet
  • Cash Flow
  • About
  • Price history
  • FAQs

Kymera Stock Performance

Open
$122.19
Prev. Close
$121.33
Circuit Range
N/A
Day Range
$120.16 - $123.52
Year Range
$63.21 - $142.41
Volume
23,682
Average Traded
$121.38

Kymera Share Price Today

As of 19 November 2026, Kymera Therapeutics, Inc.'s share price is $121.21. The stock opened at $122.19, compared to its previous close of $121.33. During today's trading session, Kymera Therapeutics, Inc.'s share price traded between $120.16 and $123.52, with an average price of $121.84. Over the past 52 weeks, the stock has recorded a high of $142.41 and a low of $63.21. In terms of performance, Kymera Therapeutics, Inc.'s share price has risen by 48.82% over the last six months and is up 78.54% on a year-on-year basis.

Kymera Share Price Chart

Line chart of the Kymera price trend over the selected period. The price fell overall, ranging from 120.14 to 124.19, ending at 121.21.
$120.16$123.52
L
Show Current Price
H

Kymera Stock Fundamentals & Key Indicators

Market Cap
$10.24B
PE Ratio (TTM)
N/A
Dividend Yield
0.00%
EPS (TTM)
$-4.09
Revenue (TTM)
$39.21B
Return On Equity (TTM)
-21.64%
Profit Margin
-794.06%
Debt to Equity
0.00
Quarterly Earnings Growth YoY
-51.76%

Kymera Quarterly Profit & Loss

All figures in USD

ParticularsDec 2025Mar 2026Jun 2026Sep 2026
Revenue$2.87$34.37$65.00$0.00
Net Profit-$86.98-$69.23-$61.21-$132.00
Net Profit Margin-3030.66%-201.43%-94.17%N/A
Income ChangeN/A20.41%11.58%-115.65%

Kymera Annual Profit & Loss

All figures in USD

Particulars2022202320242025
Revenue$46.83$78.59$47.07$39.21
Net Profit-$154.81-$146.96-$223.86-$311.35
Net Profit Margin-330.58%-187.00%-475.59%-794.06%
Income ChangeN/A5.07%-52.33%-39.08%

Kymera Balance Sheet

All figures in USD Million

Particulars2025202420232022
Non Current Assets871.6467.77170.44183.72
Current Assets871.21510.27405.32419.42
Total Assets1742.81978.04575.76603.13
Non Current Liabilities79.9474.6595.141.64
Current Liabilities83.2167.7785.6971.34
Total Liabilities163.15142.42180.79112.98
Shareholders' Equity1579.66835.62394.97490.15

Kymera Cash Flow

Annually

All figures in USD Million

Particulars2025202420232022
Operating-232.89-194.5-102.83-153.09
Investing-521.06-404.08139.8920.52
Financing990.71608.854.19153.0

About Kymera

Kymera Therapeutics Inc is a clinical-stage biopharmaceutical company dedicated to reinventing the treatment of human disease through the development of differentiated medicines that address health problems and meaningfully improve patients' lives. It is committed to novel technologies to address targets that have known disease-causing biology, but which have not been drugged, or have been inadequately drugged, often based on limitations of existing technologies. Its approach is intended to discover and develop a new generation of medicines in a disease-agnostic manner. Its product pipelines are STAT6, and IRAK4.

Kymera Historical Returns

Share price history by day, with open and close prices and the day's change
MonthOpenCloseChange %
Nov 2026
$127.47
$121.03
-4.46%
Oct 2026
$111.47
$126.69
+12.96%
Sep 2026
$117.02
$112.15
-6.64%
Aug 2026
$100.86
$120.13
+16.28%
Jul 2026
$114.11
$103.31
-9.96%
Jun 2026
$80.66
$114.74
+40.88%
May 2026
$80.78
$81.44
+0.46%
Apr 2026
$84.45
$81.07
-2.68%
Mar 2026
$90.05
$83.31
-8.84%
Feb 2026
$71.60
$91.38
+25.71%
Jan 2026
$77.83
$72.69
-6.48%
Dec 2025
$66.75
$77.73
+14.49%

Kymera Share Price FAQs